4.3 Review

Boron-based drugs as antiprotozoals

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Yi Xia et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents

Yong-Kang Zhang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Review Chemistry, Multidisciplinary

Boron-containing inhibitors of synthetases

Stephen J. Baker et al.

CHEMICAL SOCIETY REVIEWS (2011)

Article Chemistry, Medicinal

Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives

Shane R. Wilkinson et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)

Article Medicine, General & Internal

Antitrypanosomal Therapy for Chronic Chagas' Disease

Caryn Bern

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Infectious Diseases

SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

Robert T. Jacobs et al.

PLOS NEGLECTED TROPICAL DISEASES (2011)

Article Microbiology

Exploiting the Drug-Activating Properties of a Novel Trypanosomal Nitroreductase

Belinda S. Hall et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Biochemistry & Molecular Biology

Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human Pathogen Trypanosoma cruzi

Galina I. Lepesheva et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Medicine, General & Internal

Human African trypanosomiasis

Reto Brun et al.

LANCET (2010)

News Item Multidisciplinary Sciences

Malaria's Drug Miracle in Danger

Martin Enserink

SCIENCE (2010)

Article Chemistry, Medicinal

Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents

Dazhong Ding et al.

ACS MEDICINAL CHEMISTRY LETTERS (2010)

Review Chemistry, Medicinal

Current and developing therapeutic agents in the treatment of Chagas disease

Werner Apt

DRUG DESIGN DEVELOPMENT AND THERAPY (2010)

Article Infectious Diseases

NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness

Oliver Yun et al.

PLOS NEGLECTED TROPICAL DISEASES (2010)

Editorial Material Biochemistry & Molecular Biology

Not boring at all Boron is the new carbon in the quest for novel drug candidates

Philip Hunter

EMBO REPORTS (2009)

Review Biochemistry & Molecular Biology

Trypanocidal drugs: mechanisms, resistance and new targets

Shane R. Wilkinson et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)

Review Chemistry, Medicinal

Therapeutic potential of boron-containing compounds

Stephen J. Baker et al.

FUTURE MEDICINAL CHEMISTRY (2009)

Article Health Care Sciences & Services

Neglected Tropical Diseases: Moving Beyond Mass Drug Treatment To Understanding The Science

Adel Mahmoud et al.

HEALTH AFFAIRS (2009)

Article Multidisciplinary Sciences

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

Shane R. Wilkinson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Biochemistry & Molecular Biology

Drug discovery and development for neglected parasitic diseases

Adam R. Renslo et al.

NATURE CHEMICAL BIOLOGY (2006)

Review Microbiology

Drug resistance in leishmaniasis

SL Croft et al.

CLINICAL MICROBIOLOGY REVIEWS (2006)

Review Parasitology

Chemotherapy of trypanosomiases and leishmaniasis

SL Croft et al.

TRENDS IN PARASITOLOGY (2005)

Review Chemistry, Medicinal

Recent advances in the medicinal chemistry of α-aminoboronic acids, amine-carboxyboranes and their derivatives

VM Dembitsky et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)

Article Infectious Diseases

In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease

JA Urbina et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)

Article Pharmacology & Pharmacy

Drug-like properties and the causes of poor solubility and poor permeability

CA Lipinski

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)